Combination therapy with basal insulin and a GLP-1 receptor agonist can be highly effective, often allowing lower insulin doses
Innovative therapies may provide new hope for patients struggling with addiction
186 Currently, insulin potentiation therapy is practiced by over 400 therapists worldwide, and the few data available indicate that it could allow a reduction of chemotherapeutic doses without compromising efficacy
QoL, as well as biomarkers of protein metabolism were assessed in an attempt to understand the mechanism of action
A 2018 study reported that administering 5-Amino-1MQ to diet-induced obese mice, at the dose defined in the study protocol over an 11-day period, was associated with reduced body weight, decreased adipose mass, and lowered plasma cholesterol without reduced food intake, pointing to altered energy handling